---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-045012"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:44:06.682282+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Medifast Q3 2024 revenue down 40.6% to $140.2M; EPS $0.10; guides Q4 revenue $100-120M

## Summary
- Revenue $140.2M, down 40.6% YoY; net income $1.1M ($0.10 diluted EPS); adjusted EPS $0.35.
- Active earning OPTAVIA coaches fell 36.3% to 30,000; average revenue per coach $4,672 (down from $5,008).
- Cash $170M, no debt; credit facility canceled, saving ~$500k annual commitment fees.
- Q4 2024 guidance: revenue $100-120M, diluted loss per share $0.10-$0.65.

## SEC filing metadata
- accession: 0001628280-24-045012
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.02, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828024045012/0001628280-24-045012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828024045012/med-20241030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-045012
- JSON: https://secwatch.observer/filing/0001628280-24-045012.json
- Plain text: https://secwatch.observer/filing/0001628280-24-045012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.